Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-20
2006-06-20
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S333500
Reexamination Certificate
active
07064144
ABSTRACT:
Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I) wherein R1 is aryl or heterocyclic group which is optionally substituted with substituent(s); R2is lower alkyl; R3is hydroxy or protected hydroxy; -A- is lower alkylene; and —X— is —O— or —S—; provided that when then R1is aryl which is substituted with substituent(s), or heterocyclic group which is optionally substituted with substituent(s), its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
REFERENCES:
patent: 6359145 (2002-03-01), Terasaka et al.
patent: 6596738 (2003-07-01), Terasaka et al.
patent: 2004/0097571 (2004-05-01), Tsuji et al.
patent: 00/05217 (2000-02-01), None
patent: 00/55155 (2000-09-01), None
patent: 01/26605 (2001-04-01), None
patent: 01/53271 (2001-07-01), None
U.S. Appl. No. 10/169,757, filed Oct. 22, 2002, Tsuji, et al.
U.S. Appl. No. 10/483,336, filed Jan. 12, 2004, Terasaka, et al.
U.S. Appl. No. 10/503,585, filed Aug. 12, 2004, Tsuji, et al.
U.S. Appl. No. 10/483,336, filed Jun. 30, 2004, Terasaka, et al.
Kato Takeshi
Nakamura Katsuya
Terasaka Tadashi
Tsuji Kiyoshi
Astellas Pharma Inc.
Chung Susannah L.
Saeed Kamal A.
LandOfFree
Imidazole derivatives as adenosine deaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives as adenosine deaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives as adenosine deaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685581